These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7884631)

  • 1. Effect of encapsulation of chloramphenicol in albumin microspheres on its in vitro transfer across the human placenta.
    Onur MA; Vural I; Başçi N; Pamir R; Coşkun T; Işimer A; Kaş HS; Beksaç S; Hincal AA; Tümer A
    J Microencapsul; 1994; 11(6):657-62. PubMed ID: 7884631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in the placental transfer of chloramphenicol when administered in albumin microspheres into rats.
    Onur MA; Vural I; Kaş HS; Hincal AA; Coşkun T; Kanra G; Tümer A
    J Microencapsul; 1993; 10(3):367-74. PubMed ID: 8377094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium.
    Mathiesen L; Rytting E; Mose T; Knudsen LE
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):181-7. PubMed ID: 19508462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion.
    Barzago MM; Bortolotti A; Stellari FF; Diomede L; Algeri M; Efrati S; Salmona M; Bonati M
    J Pharmacol Exp Ther; 1996 Apr; 277(1):79-86. PubMed ID: 8613970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factorial design based optimization of the formulation of albumin microspheres containing adriamycin.
    Gupta PK; Hung CT; Lam FC
    J Microencapsul; 1989; 6(2):147-60. PubMed ID: 2723957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide loaded albumin microspheres II. Release characteristics.
    Vural I; Kaş HS; Hincal AA; Cavé G
    J Microencapsul; 1990; 7(4):511-6. PubMed ID: 2125078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method to prepare monodisperse microparticles.
    Muramatsu N; Nakauchi K
    J Microencapsul; 1998; 15(6):715-23. PubMed ID: 9818949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres.
    Willmott N; Cummings J; Florence AT
    J Microencapsul; 1985; 2(4):293-304. PubMed ID: 3939779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine.
    Nastruzzi C; Pastesini C; Cortesi R; Esposito E; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(3):249-60. PubMed ID: 8064549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and performance evaluation of neomycin-HSA microspheres.
    Pande S; Vyas S; Dixit V
    J Microencapsul; 1990; 7(2):155-65. PubMed ID: 2329442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
    Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
    J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal gel with chloramphenicol: characterisation and in vitro release.
    Pavelić Z; Skalko-Basnet N; Jalsenjak I
    Acta Pharm; 2004 Dec; 54(4):319-30. PubMed ID: 15634615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egg albumin microspheres containing sulphamethizole.
    Brophy MR; Deasy PB
    J Microencapsul; 1984; 1(2):157-68. PubMed ID: 6336524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microparticulate system of captopril.
    Dandagi PM; Mastiholimath VS; Patil MB; Gupta MK
    Int J Pharm; 2006 Jan; 307(1):83-8. PubMed ID: 16310990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of epirubicin containing albumin microspheres in the experimental therapy of breast cancer.
    Novotný J; Zinek K
    Neoplasma; 1994; 41(4):201-4. PubMed ID: 7935992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human serum albumin on transplacental transfer of glyburide.
    Nanovskaya TN; Nekhayeva I; Hankins GD; Ahmed MS
    Biochem Pharmacol; 2006 Aug; 72(5):632-9. PubMed ID: 16828060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of triamterene transfer across the human placenta.
    Ching MS; Czuba MA; Mihaly GW; Morgan DJ; Hyman KM; Paull JD; Smallwood RA
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1093-7. PubMed ID: 3418511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
    Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
    J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.